Detalhe da pesquisa
1.
Efficacy and safety of first-line treatment for metastatic triple-negative breast cancer: A network meta-analysis.
Cancer Pathog Ther;
2(2): 81-90, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38601487
2.
Long-term survival after neoadjuvant therapy for triple-negative breast cancer under different treatment regimens: a systematic review and network meta-analysis.
BMC Cancer;
24(1): 440, 2024 Apr 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38594636
3.
Incidence of thyroid dysfunction caused by immune checkpoint inhibitors combined with chemotherapy: A systematic review and meta-analysis.
Int Immunopharmacol;
133: 111961, 2024 May 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38608442
4.
Incidence of antibody-drug conjugate-related fatigue in patients with breast cancer: A systematic review and meta-analysis.
Crit Rev Oncol Hematol;
196: 104292, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38403093
5.
The correlation between systemic inflammatory markers and efficiency for advanced gastric cancer patients treated with ICIs combined with chemotherapy.
Immunology;
172(1): 77-90, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38269606
6.
Screening Single Nucleotide Polymorphisms Predicting the Efficacy of Electroacupuncture for Fatigue Treatment in Patients with Breast Cancer Following Adjuvant Chemotherapy.
Biochem Genet;
62(2): 1291-1303, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-37596508
7.
Incidence rate of osteonecrosis of jaw after cancer treated with bisphosphonates and denosumab: A systematic review and meta-analysis.
Spec Care Dentist;
44(2): 530-541, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-37219080
8.
Third-line Treatment for Metastatic Triple-negative Breast Cancer: A Systematic Review and Network Meta-analysis.
Am J Clin Oncol;
47(2): 91-98, 2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38108387
9.
Treatment-related adverse events of antibody-drug conjugates in clinical trials: A systematic review and meta-analysis.
Cancer Innov;
2(5): 346-375, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-38090386
10.
Elevated expression of TUBA1C in breast cancer predicts poor prognosis.
PLoS One;
18(11): e0263710, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38032902
11.
Meta-analysis of quality of life in patients with cancer treated with antibody-drug conjugates in randomized controlled trials.
Future Oncol;
19(32): 2201-2212, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37882431
12.
Cytochrome b561 regulates iron metabolism by activating the Akt/mTOR pathway to promote Breast Cancer Cells proliferation.
Exp Cell Res;
431(1): 113760, 2023 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37634562
13.
Correlation between mismatch repair and survival of patients with gastric cancer after 5-FU-based adjuvant chemotherapy.
J Gastroenterol;
58(7): 622-632, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37036516
14.
Second-line Endocrine Therapy of Hormone Receptor-positive/HER2- negative Advanced Breast Cancer: A Systematic Review and Network Meta-analysis.
Curr Cancer Drug Targets;
23(9): 718-730, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37026492
15.
Efficacy of anti-HER2 drugs in the treatment of patients with HER2-mutated cancers: a systematic review and meta-analysis.
Clin Exp Med;
23(7): 3205-3216, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37120775
16.
The association between HER2-low expression and prognosis of breast cancer: a systematic review and meta-analysis.
Ther Adv Med Oncol;
15: 17588359231156669, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36872948
17.
Treatment options for patients with human epidermal growth factor 2-positive breast cancer brain metastases: A systematic review and meta-analysis.
Front Oncol;
13: 1003565, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36890831
18.
Impact of platinum-based chemotherapy on the prognosis of early triple-negative breast cancer: a systematic review and meta-analysis.
Clin Exp Med;
23(6): 2025-2040, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-36422737
19.
Comparative efficacy and safety of first-line neoadjuvant treatments in triple-negative breast cancer: systematic review and network meta-analysis.
Clin Exp Med;
23(5): 1489-1499, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-36152119
20.
Watson for oncology decision system for treatment consistency study in breast cancer.
Clin Exp Med;
23(5): 1649-1657, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-36138331